Nalaganje...
Pharmacologic Therapies for Idiopathic Pulmonary Fibrosis, Past and Future
Idiopathic pulmonary fibrosis (IPF) is a severe, progressive fibrotic disease of the lung of unknown etiology that affects approximately 150,000 patients in the United States. It carries a median survival of two to three years, but clinical course can vary markedly from patient to patient. There has...
Shranjeno v:
| izdano v: | Ann Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4638420/ https://ncbi.nlm.nih.gov/pubmed/25613169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07853890.2014.991751 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|